Asia Pacific Defibrillator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Implantable Cardioverter Defibrillator and External) and End User (Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings, and Alternate Care Facilities)
Market Introduction
Asia-Pacific (APAC) is the fastest-growing regional market for Defibrillator; and China, India, Japan, South Korea, Australia, and rest of APAC are the major contributors to the market in this region. Asia Pacific is likely to account for over 18.34% market share of the global defibrillator market in 2021 owing to the growing investments from international players in China and India, improving government support in countries, expanding base of CRO services, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the Defibrillator market players to grow during the forecast period. The medical device industry in China has grown at a faster pace in the past several years. The factors that have enhanced the medical industry in China include continued economic growth, China’s 13th Five-Year Plan that prioritized health and innovation, increased demand for technologically advanced medical devices, significantly rising geriatric population, and growing chronic health conditions among people. In addition, the availability of low-cost and skilled laborers and massive space for production has attracted various market leaders to have their production plants in China. The Population Reference Bureau has projected that by 2050, 366 million people in China will be aged 65 or more. As per the WHO’s Ageing and health in China, in 2019, around 75% of older people that is aged 60 years or older in China suffers from noncommunicable diseases such as cardiovascular disease, diabetes and hypertension. As per the report, published in The Lancet in June 2019, by Zhou et al, the top four diseases in China with the highest mortality rate is stroke, ischemic heart disease, lung cancer, and chronic obstructive pulmonary disease (COPD), which is clearly indication towards the impact of cardiovascular diseases on people of China
The COVID-19 pandemic has broadly affected economies in Asia Pacific. The supply chain disruptions and the immense demand for efficient treatments of COVID-19 patients have put the healthcare research industry in a crucial situation in the region. Prohibitive measures have been taken to control the spread of this pandemic. A 2020 news report found an increased demand for defibrillators in India amid the pandemic. With heart failure becoming a common reason for the death of critical COVID-19 patients, the demand for defibrillators was fulfilled by various global and domestic players. Jeevtronics, an Indian startup, had scaled up its production capacity from 60 units per month to over 200 units per month to cater to the local and global demand. Also, regional cooperation and donations also saw defibrillators being distributed to countries as an essential medical device for the care of COVID-19 patients. While most nonessential surgeries in regional countries were put on hold or delayed, the demand for defibrillators was constant due to its increased demand among COVID-19 patients.
Get more information on this report : 
Market Overview and Dynamics
The defibrillator market in Asia-Pacific is expected to grow from US$ 1,921.42 million in 2021 to US$ 2,865.30 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028. Rising prevalence of cardiovascular diseases; cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality. Unhealthy lifestyles habits, including tobacco consumption, poor diet, obesity, physical inactivity, and excess alcohol consumption, are the leading causes of CVDs. The surging cases of CVDs result in high demand for defibrillators as an essential tool for resuscitation and care of CVD patients in hospitals. With a rise in national healthcare expenditures and disposable household incomes in various regions, the use of defibrillators is expected to increase further to manage CVDs better. Furthermore, amid such high demands for defibrillators as a vital instrument in hospitals, automated external defibrillators are gaining special traction owing to their suitability in the resuscitation of persons having a sudden cardiac arrest (SCA). Thus, the growing incidence of CVDs drives the demand for defibrillators of all types in hospitals, homes, and other healthcare settings. This is bolstering the growth of the defibrillator market.
Key Market Segments
Based on product, the market is segmented into implantable cardioverter defibrillator (ICD) and external. In 2020, the implantable cardioverter defibrillator segment held the largest share Asia-Pacific defibrillator market. The implantable cardioverter defibrillator is further sub-segmented into transvenous ICD and subcutaneous ICD. The transvenous ICD segment accounts for largest market share in the 2020. Similarly, the external segment is sub-segmented into manual, wearable, and fully automated external defibrillators. In 2020, the manual segment held the largest share of the market. Based on end user, the Asia-Pacific defibrillator market is segmented into hospitals and clinics, prehospital care, public access, home care settings, and alternate care facilities. The hospitals and clinics segment held the largest share of the market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the defibrillator market in Asia-Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; Biotronik, Inc; Boston Scientific Corporation; CU Medical Systems, Inc.; Koninklijke Philips N.V.; Medtronic; Nihon Kohden Corporation; Shenzhen Mindray Biomedical Electronics Co., Ltd; and ZOLL MEDICAL CORPORATION among others.
Reasons to buy report
- To understand the Asia-Pacific defibrillator market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia-Pacific defibrillator market
- Efficiently plan M&A and partnership deals in Asia-Pacific defibrillator market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia-Pacific defibrillator market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Asia-Pacific region.
ASIA-PACIFIC DEFIBRILLATOR MARKET SEGMENTATION
- Implantable Cardioverter Defibrillator
- Transvenous ICD
- Subcutaneous ICD
- External
- Manual
- Fully Automated External Defibrillators
- Wearable
- Hospitals and Clinics
- Prehospital Care
- Public Access
- Alternate Care Facilities
- Home Care Settings
By Country
- Australia
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Company Profiles
- Abbott
- Biotronik, Inc
- Boston Scientific Corporation
- CU Medical Systems, Inc.
- Koninklijke Philips N.V.
- Medtronic
- Nihon Kohden Corporation
- Shenzhen Mindray Biomedical Electronics Co., Ltd
- ZOLL MEDICAL CORPORATION
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Defibrillator Market – By Product
1.3.2 APAC Defibrillator Market – By End User
1.3.3 APAC Defibrillator Market – By Country
2. APAC Defibrillator Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Defibrillator Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 APAC – PEST Analysis
4.3 Experts Opinion
5. APAC Defibrillator Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Diseases
5.2 Market Restraints
5.2.1 Cost and Performance Issues Related to Implantable and Automated External Defibrillators
5.3 Market Opportunities
5.3.1 Strategies by Major Market Players to Expand Presence in Emerging Markets
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact Analysis
6. Defibrillator Market– APAC Analysis
6.1 APAC Defibrillator Market Revenue Forecast and Analysis
7. APAC Defibrillator Market– by Product
7.1 Overview
7.2 APAC Defibrillator Market, By Product, 2021 & 2028 (%)
7.3 Implantable Cardioverter Defibrillator
7.3.1 Overview
7.3.2 Implantable Cardioverter: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Transvenous ICD
7.3.3.1 Overview
7.3.3.2 Transvenous ICD: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Subcutaneous ICD
7.3.4.1 Overview
7.3.4.2 Subcutaneous ICD: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
7.4 External
7.4.1 Overview
7.4.2 External: APAC Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Manual
7.4.3.1 Overview
7.4.3.2 Manual: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 Fully Automated External Defibrillators
7.4.4.1 Overview
7.4.4.2 Fully Automated External: APAC Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 Wearable
7.4.5.1 Overview
7.4.5.2 Wearable: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Defibrillator Market– by End User
8.1 Overview
8.2 APAC Defibrillator Market Share by End User - 2021 & 2028 (%)
8.3 Hospitals and Clinics
8.3.1 Overview
8.3.2 Hospitals and Clinics: APAC Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Prehospital Care
8.4.1 Overview
8.4.2 Prehospital Care: APAC Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Public Access
8.5.1 Overview
8.5.2 Public Access: APAC Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)
8.6 Home Care Settings
8.6.1 Overview
8.6.2 Home Care Settings: APAC Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)
8.7 Alternate Care Facilities
8.7.1 Overview
8.7.2 Alternate Care Facilities: APAC Defibrillator Market– Revenue and Forecast to 2028 (US$ Million)
9. APAC Defibrillator Market– Country Analysis
9.1 APAC Defibrillator Market Revenue and Forecasts to 2028
9.1.1 Overview
9.1.2 APAC: Defibrillator Market Revenue and Forecasts to 2028, By Country (%)
9.1.2.1 Japan: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.1.1 Overview
9.1.2.1.2 Japan: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.1.3 Japan: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
9.1.2.1.3.1 Japan: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)
9.1.2.1.3.2 Japan: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
9.1.2.1.4 Japan: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
9.1.2.2 China: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.2.1 Overview
9.1.2.2.2 China: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.2.3 China: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
9.1.2.2.3.1 China: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)
9.1.2.2.3.2 China: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
9.1.2.2.4 China: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
9.1.2.3 India Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.3.1 Overview
9.1.2.3.2 India: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.3.3 India: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
9.1.2.3.3.1 India: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)
9.1.2.3.3.2 India: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
9.1.2.3.4 India: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
9.1.2.4 South Korea: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.4.1 Overview
9.1.2.4.2 South Korea: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.4.3 South Korea: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
9.1.2.4.3.1 South Korea: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)
9.1.2.4.3.2 South Korea: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
9.1.2.4.4 South Korea: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
9.1.2.5 Australia: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.5.1 Overview
9.1.2.5.2 Australia: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2.5.3 Australia: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
9.1.2.5.3.1 Australia: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)
9.1.2.5.3.2 Australia: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
9.1.2.5.4 Australia: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
9.1.2.6 Rest of APAC: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.6.1 Overview
9.1.2.6.2 Rest of APAC: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.6.3 Rest of APAC: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
9.1.2.6.3.1 Rest of APAC: Defibrillator Market, by Implantable Cardioverter Defibrillator, 2019–2028 (US$ Million)
9.1.2.6.3.2 Rest of APAC: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
9.1.2.6.4 Rest of APAC: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10. Impact Of COVID-19 Pandemic on APAC Defibrillator Market
10.1 APAC: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Biotronik, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ZOLL MEDICAL CORPORATION
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Nihon Kohden Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CU Medical Systems, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Shenzhen Mindray Biomedical Electronics Co., Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. Japan: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 3. Japan: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)
Table 4. Japan: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
Table 5. Japan: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 7. China: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)
Table 8. China: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
Table 9. China: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. India: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 11. India: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)
Table 12. India: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
Table 13. India: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 15. South Korea: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
Table 17. South Korea: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 19. Australia: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
Table 21. Australia: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of APAC: Defibrillator Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 23. Rest of APAC: Defibrillator Market, by Implantable Cardioverter Defibrillator – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of APAC: Defibrillator Market Revenue and Forecasts to 2028, By External (US$ Million)
Table 25. Rest of APAC: Defibrillator Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Organic Developments Done By Companies
Table 27. Inorganic Developments Done By Companies
Table 28. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Defibrillator Market Segmentation
Figure 2. APAC Defibrillator Market Segmentation, By Country
Figure 3. APAC Defibrillator Market Overview
Figure 4. Implantable Cardioverter Defibrillator (ICD) Held the Largest Share of the Product Segment in APAC Defibrillator Market
Figure 5. China to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. APAC Defibrillator Market Impact Analysis of Drivers and Restraints
Figure 8. APAC Defibrillator Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. APAC Defibrillator Market, by Product, 2021 & 2028 (%)
Figure 10. Implantable Cardioverter: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 11. Transvenous ICD: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Subcutaneous ICD: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. External: APAC Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Manual: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Fully Automated External: APAC Defibrillators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Wearable: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. APAC Defibrillator Market Share by End User - 2021 & 2028 (%)
Figure 18. Hospitals and Clinics: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Prehospital Care: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Public Access: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Home Care Settings: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Alternate Care Facilities: APAC Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. APAC Defibrillator Market Overview, by Country (2021)
Figure 24. APAC: Defibrillator Market Revenue and Forecasts to 2028, By Country (%)
Figure 25. Japan: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. China: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. India: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. South Korea: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Australia: Defibrillator Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Rest of APAC: Defibrillator Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Impact of COVID-19 Pandemic in APAC Country Markets
- Abbott
- Biotronik, Inc
- Boston Scientific Corporation
- CU Medical Systems, Inc.
- Koninklijke Philips N.V.
- Medtronic
- Nihon Kohden Corporation
- Shenzhen Mindray Biomedical Electronics Co., Ltd
- ZOLL MEDICAL CORPORATION
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia-Pacific Defibrillator Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia-Pacific Defibrillator Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia-Pacific market trends and outlook coupled with the factors driving the Defibrillator Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution